Protein C (PROC) deficiency is caused by mutations in the PROC gene on chromo some 2q14.3. Patients with PROC deficiency typically present distinguished purpura, intracerebral and intravascular coagulopathy, and ophthalmologic complications. Here, we report a rare severe form of PROC deficiency resulting from a compound heterozygosity in PROC. The patient was a 5dayold female neonate born at 39 weeks of gestation with a birth weight of 2,960 g. She was transferred to our hospital with running a fever at 38.5°C and with dark red patches on her feet. At admission, a complete blood count showed no specific findings, but levels of PROC and protein S were abnormally low (1% and 68%, respectively). Magnetic resonance imaging re vealed intracerebral hemorrhaging and parenchymal damage with dysplasia of the brain. Ophthalmologic examination revealed vitreous hemorrhaging with retinal detachment. Genetic testing revealed a missense mutation (Arg211Trp) and a frame shift mutation (Gly239Serfs*8) in PROC, inherited from the father and mother, res pectively. The patient recovered from purpura after undergoing ventriculoperi toneal shunting and treatment with fresh frozen plasma, warfarin sodium, and PROC con cen trate. This is the first report of severe neonatal PROC deficiency with purpura fulminans, vitreous hemorrhage, and intracerebral hemorrhage confirmed via PROC genetic testing, which identified a rare compound heterozygosity of PROC.
INTRODUCTION
Congenital protein C (PROC) deficiency is a welldocumented autosomal dominant disorder of variable penetrance. Over 150 mutations have been reported 1) . PROC, located on chromosome 2q14.3 is approximately 10,802 bp and contains 9 exons (1,790 bp), 8 of which encode the protein 24) .
Severe PROC deficiency (PROC activity <1 IU/dL) is a rare autosomal recessive disorder; its chief presentations include neonatal purpura fulminans and severe disseminated intravascular coagulation (DIC) with concomitant venous thromboembolism 5) . The incidence of clinically significant PROC deficiency is estimated to be 1 in 20,000 6) . In this study,
we describe the first genetically verified case of severe PROC deficiency in Korea.
CASE REPORT
The patient was a 5dayold female neonate, born by vaginal delivery at 39 weeks of gestation with a birth weight of 2,960
g. The patient is the first child of a mother with no remarkable medical nor obstetric history (G1, P1, A0, D0, L1). No unusual events were reported during the first 3 days after birth; however, on the 4th day, the patient was admitted to the hospital after her body temperature rose to 38.5°C. On the 5th day, the skin on her . Other major morbidities, such as renal failure, epilepsy, and impaired growth and development, have also been reported.
Only 3 patients have been reported to not exhibit any major morbidity because of early onset of treatment and continuous therapy with PROC concentrate 19, 20) .
Overall, the present study describes a case of severe PROC deficiency in a neonate that presented purpura fulminans, vitreous hemorrhage, and intracerebral hemorrhage. The diagnosis was confirmed by identification of a rare compound heterozygosity in PROC.
the purpura.
The patient underwent extracapsular cataract extraction via phacoemulsification and synechiolysis at 3 months of age. The posthemorrhagic hydrocephaly was also treated by external ventricular drainage and ventriculoperitoneal shunting at 5 months of age. She was discharged at 6 months of age and her PROC levels, prothrombin time, and activated partial thrombo plastin were reassessed every 6 months.
DISCUSSION
The incidence of asymptomatic and clinically significant PROC deficiency has been reported to be 1 in 200500 and 1 in 20,000 healthy individuals, respectively 5, 7) . Although there have been several cases of purpura fulminans in the Korean population that were suspected to be due to PROC deficiency, none were genetically confirmed via identification of mutations in PROC 8) .
Diagnostic testing for PROC deficiency typically relies on functional assays such as chromogenic assays containing snake venom, clotting assays, and enzymelinked immunosorbent assays 5) . However, in addition to these assays, genetic testing for mutations in PROC located on chromosome 2q14.3 was also needed 9) .
For a healthy term infant, the average PROC level is 40%, with mild deficiency diagnosed for values up to 20%, moderateto severe deficiency at 120%, and severe deficiency at <1% or if PROC is undetectable 5, 10) . In the present case, the patient had PROC levels of 1% upon admission.
Infants with severe congenital PROC deficiency typically pre sent rapidly progressive purpura fulminans and DIC within hours of birth 11) . Purpura fulminans begins with red or purpuric lesions caused by application of mild pressure, which eventually forms painful, palpable black eschars. Most affected infants manifest white light reflexes and are congenitally blind due to thrombosis in the developing vitreal vein. On brain MRIs, many infants show evidence of prenatal arterial ischemic stroke or cerebral hemorrhage 12) . Large vessel thrombosis, including renal vein thrombosis, has been reported in some infants 13) . Pur pura fulminans is triggered by infection, trauma, and even minor decreases in levels of therapeutic anticoagulants 14, 15) . The present patient exhibited purpura fulminans, DIC, congenital blindness, and brain involvement, visual impairment and delayed develop ment by 1 year of age.
